1466 / 1816
RISAS study (NCT02800317)
Primary Radioactive Iodine Seed Localisation in the Axilla in Axillary Node Positive Breast Cancer
Combined With Sentinel Node Procedure (RISAS) Following Neoadjuvant Chemotherapy
breast surgery, an expected average of 4 months. ]
•
MARI i.c.w. SN, followed by ALND in The Netherlands, recruiting:
•
Primary outcome:
•
Identification rate and accuracy (sensitivity, negative predictive
value (NPV) and false negative rate (FNR)) for identifying
axillary pCR
•
Secondary outcome:
•
Same as primary, but then for MARI and SN separately
•
Number of patients:
•
200 patients to be included from October 2016-October 2018